Ciploxx 250mg / 500mg Tablets
PDF Leaflet Revision Date: 21 November 2025
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of severe and/or complicated infections caused by ciprofloxacin-sensitive bacteria.
Dosage (summary)
250 to 750 mg twice daily; 750 mg for severe lower respiratory and skin infections.
Special Populations
- Elderly
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Not established for safety in pregnancy; contraindicated in breastfeeding due to potential articular damage.
Key Drug Interactions
- Tizanidine
- Methotrexate
- Theophylline
- Warfarin
Contraindications
- Children under 18
- Hypersensitivity to ciprofloxacin
- Myasthenia gravis
- Aortic aneurysm
Common side effects
- Nausea
- Diarrhoea
- Dizziness
- Headache
- Rash
Counselling Points
- Avoid dairy products during treatment
- Monitor for severe skin reactions
- Stay hydrated to prevent crystalluria
Serious warnings
- Severe cutaneous adverse reactions
- Tendon rupture
- QT prolongation
Important Disclaimer
The Ciploxx 250mg / 500mg Tablets professional information leaflet below is the property of Cipla Medpro and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
